United States
Germany
Japan
United Kingdom
China
Anti-RALBP1 (RIP1) mouse monoclonal antibody, clone OTI2A6 (formerly 2A6)
| Applications | IF, IHC, IP, WB |
| Reactivities | Human, Mouse, Rat |
Antibodies
GBA mouse monoclonal antibody, clone OTI1D12
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
ASS1 mouse monoclonal antibody,clone OTI12G1
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
Anti-MAPK1 (ERK2) mouse monoclonal antibody, clone OTI4C2 (formerly 4C2)
| Applications | IF, IHC, IP, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
CDX2 mouse monoclonal antibody,clone OTI3B1
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
CNY 1,999.00
CNY 2,700.00
现货
NR3C1 mouse monoclonal antibody, clone OTI6A12 (formerly 6A12)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
Anti-STAT3 mouse monoclonal antibody, clone OTI21E7 (formerly 21E7)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
Anti-ANXA1 (Annexin A1) mouse monoclonal antibody, clone OTI3A8 (formerly 3A8)
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
CNY 800.00
现货
SH3GL1 mouse monoclonal antibody, clone OTI2F5 (formerly 2F5)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
FGFR3 mouse monoclonal antibody, clone OTI1B10 (formerly 1B10)
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
Anti-MAPK1 (ERK2) mouse monoclonal antibody, clone OTI4C2 (formerly 4C2)
| Applications | IF, IHC, IP, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
CDX2 mouse monoclonal antibody,clone OTI3B1
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
GBA mouse monoclonal antibody, clone OTI1D12
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
活动过滤器
优化搜索结果
Category
Target Symbol
Antibody Hosts
Clonalities
Families
Pathways
- Pathways in cancer (9)
- Chemokine signaling pathway (6)
- Pancreatic cancer (6)
- Acute myeloid leukemia (5)
- Focal adhesion (5)
- Insulin signaling pathway (5)
- MAPK signaling pathway (5)
- Metabolic pathways (5)
- Regulation of actin cytoskeleton (5)
- Bladder cancer (4)
- Endocytosis (4)
- ErbB signaling pathway (4)
- Fc gamma R-mediated phagocytosis (4)
- VEGF signaling pathway (4)
- Adipocytokine signaling pathway (3)
- Apoptosis (3)
- Axon guidance (3)
- B cell receptor signaling pathway (3)
- Chronic myeloid leukemia (3)
- Colorectal cancer (3)
- Endometrial cancer (3)
- Fc epsilon RI signaling pathway (3)
- Glioma (3)
- Jak-STAT signaling pathway (3)
- Melanoma (3)
- Neurotrophin signaling pathway (3)
- Non-small cell lung cancer (3)
- Progesterone-mediated oocyte maturation (3)
- Prostate cancer (3)
- Renal cell carcinoma (3)
- T cell receptor signaling pathway (3)
- Toll-like receptor signaling pathway (3)
- mTOR signaling pathway (3)
- Adherens junction (2)
- Alzheimer's disease (2)
- Dorso-ventral axis formation (2)
- Fructose and mannose metabolism (2)
- Galactose metabolism (2)
- Gap junction (2)
- Glycolysis / Gluconeogenesis (2)
- GnRH signaling pathway (2)
- Leukocyte transendothelial migration (2)
- Long-term depression (2)
- Long-term potentiation (2)
- Lysosome (2)
- Melanogenesis (2)
- NOD-like receptor signaling pathway (2)
- Natural killer cell mediated cytotoxicity (2)
- Oocyte meiosis (2)
- Other glycan degradation (2)
- Pentose phosphate pathway (2)
- Prion diseases (2)
- Small cell lung cancer (2)
- Sphingolipid metabolism (2)
- TGF-beta signaling pathway (2)
- Thyroid cancer (2)
- Type II diabetes mellitus (2)
- Vascular smooth muscle contraction (2)
- Alanine (1)
- Arginine and proline metabolism (1)
- Neuroactive ligand-receptor interaction (1)
- Tight junction (1)
- aspartate and glutamate metabolism (1)
